Andrea Macko reports in Porcupine Soup that the independently owned pharmacy located in the Greene Medical Arts Building under the ownership of Ravinder Annamneni agreed to pay $65,000 after allegations that it failed to comply with the federal Controlled Substances Act. A 2022 U.S. Drug Enforcement Administration audit of the Greene Medical Arts Pharmacy showed they failed to keep adequate records of various controlled substances, including oxycodone, hydrocodone, alprazolam, methylphenidate, and buprenorphine. The U.S. Attorney’s Office said, “Greene Pharma subsequently performed a self-audit of its controlled substance records and was unable to account for 200 oxycodone tablets, 144 buprenorphine films, and two buprenorphine tablets, which the pharmacy concluded were likely stolen by an employee who had not been adequately screened before employment.” Read more about this story in Porcupine Soup.